HomeInvestors HealthAstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy... AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition (AZN:NASDAQ) By BOMAR ENT. March 17, 2025 FacebookTwitterPinterestWhatsApp Roland Magnusson EsoBiotec SA has entered into a definitive agreement to be acquired by AstraZeneca (NASDAQ:AZN) for up to $1 billion, on a cash and debt-free basis, it said on Monday. The deal includes an initial payment of $425 million on closing, and up Source link Previous articleBeating the StreetNext articleKnit Socks!: 17 Classic Patterns for Cozy Feet latest articles explore more Big income trading Trading Investment Cryptocurrency Stocks Forex Options Futures Trading Strategies Risk Management Technical Analysis Fundamental Analysis A New Fed Chairman is Coming Soon—Here’s What Their Potential Low-Rate Policy Will Mean For Investors The 1-Minute Market Report, December 7, 2025 The Day Trading & Swing Trading Playbook: The Strategic Art of Printing Your Own Money & Building Wealth in Any Market (The Stock Market... Christian Convert from Sudan Expelled from Home in Uganda Artificial Intelligence For Dummies (For Dummies (Computer/Tech)) LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
